Dr. Andrew Moran is a program director, researcher and a general practice physician. Dr. Moran’s chief interests are in hypertension control and cardiovascular disease prevention, with a particular focus on prevention in low- and middle-income countries.
Dr. Moran is Director, Global Hypertension Control, at Resolve to Save Lives where he supports expansion of systematic hypertension control programs in 31 low- and middle-income countries. In this role, he provides clinical, technical and logistics support to in-country partners implementing hypertension control programs.
At Columbia University, Dr. Moran leads predictive modeling and economic analyses of major clinical trials, including the landmark SPRINT trial of intensive blood pressure treatment, and the Los Angeles Barber-Pharmacist blood pressure lowering trial, which tested a barber-pharmacist collaboration to treat hypertension in African American men visiting barbershops in Los Angeles, California. He is also leading research projects related to national cardiovascular disease prevention policies, including early prevention in young adults and the optimal approach to screening and treatment of familial hypercholesterolemia (one of three Tier 1 genomic conditions).
Dr. Moran led the global burden of ischemic heart disease analysis for the Global Burden of Disease 2010 Study and the cardiovascular disease clinical care quality section of the Disease Control Priorities in Developing Countries, third edition (DCP3) project. He served on the 2021 hypertension guideline development group at the World Health Organization and serves on the board of the World Hypertension League.